Bordi P - Search Results

1

Clinical and hematologic parameters address the outcomes of non-small-cell lung cancer patients treated with nivolumab.

Facchinetti F, Veneziani M, Buti S, Gelsomino F, Squadrilli A, Bordi P, Bersanelli M, Cosenza A, Ferri L, Rapacchi E, Mazzaschi G, Leonardi F, Quaini F, Ardizzoni A, Missale G, Tiseo M. Facchinetti F, et al. Among authors: bordi p. Immunotherapy. 2018 Jun;10(8):681-694. doi: 10.2217/imt-2017-0175. Immunotherapy. 2018. PMID: 29882691

2

Emerging role of gefitinib in the treatment of non-small-cell lung cancer (NSCLC).

Tiseo M, Bartolotti M, Gelsomino F, Bordi P. Tiseo M, et al. Among authors: bordi p. Drug Des Devel Ther. 2010 May 25;4:81-98. doi: 10.2147/dddt.s6594. Drug Des Devel Ther. 2010. PMID: 20531963 Free PMC article.

3

Anaplastic lymphoma kinase as a new target for the treatment of non-small-cell lung cancer.

Tiseo M, Gelsomino F, Bartolotti M, Bordi P, Bersanelli M, Rossi G, Ardizzoni A. Tiseo M, et al. Among authors: bordi p. Expert Rev Anticancer Ther. 2011 Nov;11(11):1677-87. doi: 10.1586/era.11.157. Expert Rev Anticancer Ther. 2011. PMID: 22050016 Review.

4

Narrative literature and cancer: improving the doctor-patient relationship.

Aitini E, Bordi P, Dell'agnola C, Fontana E, Liguigli W, Quaini F. Aitini E, et al. Among authors: bordi p. Tumori. 2012 Nov;98(6):152e-4e. doi: 10.1700/1217.13510. Tumori. 2012. PMID: 23389373

5

ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin.

Tiseo M, Bordi P, Bortesi B, Boni L, Boni C, Baldini E, Grossi F, Recchia F, Zanelli F, Fontanini G, Naldi N, Campanini N, Azzoni C, Bordi C, Ardizzoni A; Bio-FAST trial group. Tiseo M, et al. Among authors: bordi p, bordi c. Br J Cancer. 2013 Apr 30;108(8):1695-703. doi: 10.1038/bjc.2013.127. Epub 2013 Apr 2. Br J Cancer. 2013. PMID: 23549037 Free PMC article. Clinical Trial.

6

Overcoming T790M-driven acquired resistance to EGFR-TKIs in NSCLC with afatinib: a case report.

Bordi P, Tiseo M, Bortesi B, Naldi N, Buti S, Ardizzoni A. Bordi P, et al. Tumori. 2014 Jan-Feb;100(1):e20-3. doi: 10.1700/1430.15832. Tumori. 2014. PMID: 24675505

7

Gene mutations in small-cell lung cancer (SCLC): results of a panel of 6 genes in a cohort of Italian patients.

Bordi P, Tiseo M, Barbieri F, Bavieri M, Sartori G, Marchetti A, Buttitta F, Bortesi B, Ambrosini-Spaltro A, Gnetti L, Silini EM, Ardizzoni A, Rossi G. Bordi P, et al. Lung Cancer. 2014 Dec;86(3):324-8. doi: 10.1016/j.lungcan.2014.10.002. Epub 2014 Oct 12. Lung Cancer. 2014. PMID: 25453846

8

Efficacy and safety of long-term tolvaptan treatment in a patient with SCLC and SIADH.

Bordi P, Tiseo M, Buti S, Regolisti G, Ardizzoni A. Bordi P, et al. Tumori. 2015 Apr 28;101(2):e51-3. doi: 10.5301/tj.5000249. Tumori. 2015. PMID: 25702667

9

Predictive role of erythrocyte macrocytosis during treatment with pemetrexed in advanced non-small cell lung cancer patients.

Buti S, Bordi P, Tiseo M, Bria E, Sperduti I, Di Maio M, Panni S, Novello S, Rapetti SG, Pilotto S, Genestreti G, Rossi A, Pezzuolo D, Camisa R, Tortora G, Ardizzoni A. Buti S, et al. Among authors: bordi p. Lung Cancer. 2015 Jun;88(3):319-24. doi: 10.1016/j.lungcan.2015.03.016. Epub 2015 Apr 1. Lung Cancer. 2015. PMID: 25870156 Free article.

10

Radiotherapy of non-small-cell lung cancer in the era of EGFR gene mutations and EGF receptor tyrosine kinase inhibitors.

Moschini I, Dell'Anna C, Losardo PL, Bordi P, D'Abbiero N, Tiseo M. Moschini I, et al. Among authors: bordi p. Future Oncol. 2015;11(16):2329-42. doi: 10.2217/fon.15.156. Future Oncol. 2015. PMID: 26260811 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters